What are GLP-1 Receptor Agonists?
GLP-1 (glucagon-like peptide-1) is a natural hormone released by the small intestine in response to food intake. This hormone plays a crucial role in regulating blood sugar levels, appetite, and satiety. GLP-1 receptor agonists are synthetic medications that mimic this natural action by binding to GLP-1 receptors throughout the body. The GLP-1 hormone is part of the incretin system, a complex regulatory mechanism that is activated after food intake to stimulate insulin secretion and send appetite-suppressing signals to the brain.
The discovery of GLP-1's potential was a revolutionary moment in medicine. These medications were originally developed in the 1990s to treat type 2 diabetes, where they proved excellent as glucose regulators. However, clinical observations showed that patients were also losing significant weight. Subsequent research, particularly the groundbreaking STEP trials, demonstrated that GLP-1 agonists powerfully suppress appetite and achieve remarkable weight loss. This insight led to the development of higher-dose versions specifically designed for weight loss, providing the medical world with a highly effective new tool.
Several different GLP-1 agonists are available, each with its own characteristics and action profile. The most well-known are semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and liraglutide (Saxenda). Semaglutide works selectively on GLP-1 receptors, while tirzepatide works as a dual agonist also targeting GIP receptors. Go Leaner recommends which is most suitable for you based on your health, preferences and goals. Each medication has specific advantages and may better suit certain patient profiles.
How Do GLP-1 Medications Work?
GLP-1 receptor agonists work at multiple levels simultaneously, which explains their remarkable effectiveness. In the hypothalamus (the brain's hunger center), they reduce hunger sensitivity through changes in neuropeptide Y and pro-opiomelanocortin (POMC) signaling. At the same time, they enhance satiety signals, resulting in reduced food intake without feeling uncomfortably full. This central mechanism is crucial for the sustained success of treatment, as it normalizes rational food intake rather than imposing unsustainable diets.
Beyond the brain action, the medication slows gastric emptying (also called gastroparesis), meaning food stays in your stomach longer. This mechanism significantly prolongs satiety after eating, leading to lower daily calorie intake without deprivation. The medication also improves insulin sensitivity by normalizing receptor levels, resulting in more stable blood sugar throughout the day. This effect is particularly valuable because it prevents wild blood sugar swings that trigger hunger.
An important side effect is that GLP-1 medications fundamentally change your preference for high-calorie, fatty foods. This doesn't happen through willpower, but through biological changes in how your brain perceives food rewards. Patients consistently report less desire for fast food, chips, desserts, and other ultra-processed calorie bombs. This reduced 'food noise' makes it much easier to make healthy food choices. It also decreases binge eating and 'food cravings' that were major obstacles for many people.
The mechanism of action of GLP-1 medications is also valuable in preventing weight regain. Because the medication works with your body's natural regulatory systems (the incretin system), it supports more sustainable weight maintenance than many other approaches.
Available GLP-1 Medications
Several GLP-1 agonists are available, each with its own strengths. Here we detail the most commonly used options:
Ozempic / Wegovy (Semaglutide)
Semaglutide is the most widely used and extensively studied GLP-1 agonist in the world, FDA-approved in 2005 for diabetes and 2021 for weight loss. Ozempic contains lower doses (0.5-1 mg per week) aimed at glucose control in type 2 diabetes, while Wegovy contains higher doses (2.4 mg per week) specifically optimized for weight loss. Both are administered once weekly via subcutaneous injection using a simple self-injection pen. Semaglutide has a half-life of approximately seven days, enabling once-weekly dosing.
In the STEP trials, patients on Wegovy lost an average of 15-18% of their body weight within 68 weeks, compared to only 2-3% on placebo. These findings made semaglutide (Wegovy) the most recommended first-line medication for many patients.
Mounjaro (Tirzepatide)
Tirzepatide is a revolutionary dual-action medication (GLP-1/GIP agonist) available since 2022 that offers several advantages over single-acting agonists. It binds to both GLP-1 and GIP receptors, potentially delivering even better results by utilizing multiple natural regulatory pathways. Also a once-weekly injection, typically with faster and higher weight loss percentages than semaglutide.
In the SURMOUNT trials, patients on tirzepatide achieved weight loss of 20-22% after 68 weeks on the highest dose, significantly better than semaglutide. This makes Mounjaro an attractive option for patients seeking maximum weight loss or those for whom semaglutide provided insufficient effect.
Saxenda (Liraglutide)
Liraglutide is an older GLP-1 agonist (FDA-approved in 2014) that requires daily injections instead of once weekly. It has a much shorter half-life (approximately 13 hours), requiring daily dosing. Liraglutide is less effective than semaglutide or tirzepatide and is now prescribed less frequently, but may be an option for certain patients.
More information about our available medications: Ozempic & Wegovy in detail, Mounjaro in detail
Clinical Studies and Proven Effectiveness
The effectiveness of GLP-1 agonists has been extensively studied in large-scale, randomized clinical trials. These studies form the scientific foundation for recommendations in hospitals and clinics.
The STEP trials (Semaglutide Treatment Effect in People with obesity) were the primary evidence for semaglutide (Wegovy) in weight loss. Notably, STEP 1 demonstrated that patients lost an average of 15.3% of body weight over 68 weeks when receiving weekly 2.4 mg semaglutide, compared to only 2.6% in the placebo group. This represented a loss of approximately 15-18 kg at an average starting weight of about 100 kg. Serious adverse events were rare, and most patients were very satisfied.
The SUSTAIN trials evaluated semaglutide in patients with type 2 diabetes and showed weight loss of 12-15% in diabetic patients, with the bonus of improved glucose control. Although these percentages appear lower than in the STEP trials, this was because diabetic patients were often heavier and older. The absolute weight losses were substantial (12-17 kg on average).
The more recent SURMOUNT trials with Mounjaro (tirzepatide) demonstrated even better results through the dual-receptor approach: an average of 20-22% weight loss in one year at the highest dose (15 mg). In some patients, weight loss of up to 25% was achieved. Furthermore, these trials showed that patients on tirzepatide also experienced significant improvements in metabolic health, with better blood pressure, cholesterol, and blood sugar levels.
What is particularly valuable for patients is that the weight loss is not only significant but also sustainable. Follow-up studies show that patients maintain the weight they've lost, even after gradually discontinuing the medication, especially if they've improved their lifestyle. This contrasts sharply with many diets, where people quickly regain weight.
Additionally, GLP-1 medications have demonstrated cardiac benefits. The SELECT study (with semaglutide) showed not only weight loss but also reduction in heart attacks and strokes in people with excess weight and existing heart disease. This makes GLP-1 medications valuable beyond weight loss alone.
Who is GLP-1 Medication Suitable For?
GLP-1 medication is not suitable for everyone. Go Leaner performs careful screening to determine if you're a good candidate.
GLP-1 medication is primarily suitable for adults (18+) with overweight or obesity. The standard BMI criteria are: BMI of 30 or higher (obesity), or BMI of 27-29.9 (overweight) if you have significant health risks. These health risks may include: type 2 diabetes, heart disease, high blood pressure, sleep apnea, or other weight-related conditions.
You may not be suitable (contraindications) if you are pregnant or planning to become pregnant within two months (GLP-1 medications can in very rare cases cause abnormalities), if you have a medical history of medullary thyroid carcinoma or family history of this rare cancer type, or if you use certain other medications that interact poorly with GLP-1. Our board-registered physicians perform comprehensive health screening.
The medication is most effective if you're willing to gradually improve your eating habits and activity level. GLP-1 helps tremendously with appetite suppression and preference for healthy food, but success also requires your effort. We therefore provide coaching on nutrition and lifestyle to help you reach your full potential.
People with thyroid or pancreas history, kidney disease, or severe stomach issues need special screening. That's why Go Leaner always performs comprehensive medical evaluation before starting.
GLP-1 and Lifestyle Change: Why Both Are Needed
Although GLP-1 medications are very effective for weight loss, they are most powerful when combined with lifestyle changes.
A common misconception is that GLP-1 medication is 'the answer' and you don't need to do anything else. This is incorrect. The medication suppresses your appetite and reduces your preference for unhealthy food, making healthy choices much easier. But you still need to make those healthy choices. Actually, this is good: it gives you control over your health, rather than being dependent on medication alone.
Nutrition is the most critical component. With GLP-1, you automatically save many calories because you eat less and crave junk food less. But the quality of what you eat still matters. Our nutrition coaches help you build healthy eating patterns: more protein, more vegetables, less refined sugars. This isn't just for weight loss, but also for long-term health and energy.
Exercise is the second pillar. GLP-1 can help you lose weight, but exercise helps you keep it off and keeps your metabolism healthy. Even moderate exercise (20-30 minutes of jogging or fitness 3-4 times per week) makes a huge difference. Plus: exercise improves your mood, sleep quality, and energy levels. voeding begeleiding
The third component is psychological. Many people have emotional eating or stress eating as an issue. GLP-1 helps with the biological aspect, but you may also benefit from coaching to better manage stress. Go Leaner's lifestyle specialists help with this too.
Common Mistakes When Using GLP-1
Most patients do well, but there are several common mistakes we want to help you avoid.
Mistake #1: Escalating medication too quickly. GLP-1 works best with slow, gradual dose escalation (titration). This helps your body adapt and minimizes side effects. Patients who try to reach high doses quickly experience more nausea and are more likely to give up.
Mistake #2: Wrong food planning. With GLP-1 you can eat much less and feel full faster. But you still need adequate nutrition. Many patients eat too little protein or vegetables initially. This leads to fatigue and muscle changes. Eat smaller portions but ensure quality.
Mistake #3: Neglecting fluid intake. GLP-1 can cause constipation. You really need to drink well (water, unsweetened tea). Most patients who do this have little to no constipation.
Mistake #4: Stopping when uncomfortable. Minor side effects in weeks 1-2 are completely normal and go away. Patients who stop at first nausea miss out on the benefits. Follow your escalation schedule.
Mistake #5: No lifestyle changes. Medication alone provides only part of the desired effect. Patients who remain sedentary and eat junk food will have less benefit.
The Treatment Process at Go Leaner
Our approach is holistic and patient-centered. Here's how we work.
At Go Leaner, we don't just start with a prescription. Your treatment begins with a comprehensive assessment with a board-registered physician. This consultation takes at least 30 minutes and includes your complete medical history, current health, medication use, lifestyle, previous diet attempts, and goals. We want to truly understand you as a person, not just as a 'weight loss case'.
If you're deemed suitable, your physician prescribes the medication and guides you through the escalation schedule. For the first few weeks you use a low dose, which we gradually increase. This minimizes side effects and gives your body time to adapt. You receive detailed instructions for injections, diet, fluid intake, and what to expect. You have direct access to our team via app/email for questions.
You receive support from our nutrition coaches (dietitians) and lifestyle specialists. These aren't just generic tips, but personal coaching tailored to your preferences, goals, and family situation. We help you build healthy eating patterns rather than imposing rules on you.
Monthly, we evaluate your progress. Not just the scale, but how you feel, side effects, energy, muscle strength, and your experiences. Based on this, we may adjust medication dosing or make coaching adjustments. This means you don't just get a prescription, but a complete treatment program with human guidance from beginning to end.
Learn more about our complete treatment process →
Costs and Insurance
We're transparent about costs because financial barriers shouldn't prevent you from becoming healthy.
The cost of GLP-1 medication varies depending on which medication you receive and which package you choose. At Go Leaner, physician consultations, coaching, and monthly evaluations are included in one transparent monthly price. Medication costs vary per medication (semaglutide, tirzepatide, liraglutide have different prices) and are mapped separately.
Unfortunately, GLP-1 medication for weight loss is generally not covered by health insurers in the Netherlands, as it's considered 'lifestyle' rather than medical necessity. This is debatable since the medication provides significant health benefits. However: patients with type 2 diabetes may sometimes get coverage for Ozempic through their health insurer, depending on their specific policy. Consult your insurer for exact terms.
Go Leaner offers a single Basic Plan at €199 per month, minimum 6 months, with all medical guidance (intake, blood test, monthly physician check-in and lifestyle coaching). Medication is billed separately by the pharmacy. If you want extra support, you can add optional services à la carte (personal training, extra coaching, supplement package or extra blood test) at a rate on request. Many patients say it's much cheaper long-term than years of failed diets, gym memberships and health costs from excess weight.
View our detailed pricing and packages →
Frequently Asked Questions about GLP-1
Related Articles
Side Effects Guide
Everything about side effects and how to manage them
Ozempic Dosing
Dosing schedules and titration protocol
Nutrition with GLP-1
Meal plans and nutrition tips for better results
Medication Comparison
Ozempic, Wegovy and Mounjaro compared
Bronnen
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216.
- Pi-Sunyer X et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE). N Engl J Med 2015;373:11-22.
- Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 2018;27:740-756.
- EMA – Ozempic productinformatie (EPAR)
- EMA – Wegovy productinformatie (EPAR)
- EMA – Mounjaro productinformatie (EPAR)
- Zorginstituut Nederland – Farmacotherapeutisch Kompas: GLP-1-agonisten
The information on this page is informational and does not replace medical advice. GLP-1 medication is prescription medication and should always be under medical supervision. Always consult your physician or Go Leaner before starting treatment. This guide is based on scientific evidence and clinical experience, but individual situations may vary.